News

  1. Jan
  2. Feb
  3. Mar
  4. Apr
  5. May
  6. Jun
  7. Jul
  8. Aug
  9. Sep
  10. Oct
  11. Nov
  12. Dec

June

Jun.01, 2020 Release
FDA Accepts Shionogi’s Supplemental New Drug Application with Priority Review for FETROJA® (cefiderocol) for the Treatment of Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia

April

Apr.28, 2020 Release
Shionogi Accelerates Development of Potential COVID-19 Treatments and Vaccine

February

Feb.24, 2020 Release
Shionogi’s FETROJA® (cefiderocol) Now Available for the Treatment of Complicated Urinary Tract Infections in the U.S.
To improve your experience, this website uses cookies for analytics and functionality purposes. More information about how we use cookies and how you can control them is in our Cookie Policy. By continuing to use our website you agree to our use of these cookies.